Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paton

Showing results (351-360 of 4,763) with videos related to

Pageof 477
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's diseaseD M Paton
Neuron|April 8, 2006
Shining light on spike timing-dependent plasticityMartha Constantine-Paton
Psychopharmacology Bulletin|January 1, 1994
Effects of NMDA receptor antagonists on the developing brainM Constantine-Paton
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1984
Classification of adenosine receptorsD M Paton
The Journal of Nursing Education|December 4, 2009
The professional practice knowledge of nurse preceptorsBrenda I Paton
Drugs of Today (Barcelona, Spain : 1998)|October 28, 2022
Somapacitan: a long-acting growth hormone derivative for treatment of growth hormone deficiencyDavid M Paton
International Journal of Clinical Pharmacology Research|January 1, 1986
Comparative bioavailability and half-lives of cloxacillin and flucloxacillinD M Paton
Postgraduate Medical Journal|January 24, 2013
Republished: perception of lung function, adherence to inhaled corticosteroids, and the role of peak expiratory flow feedback in paediatric asthmaJames Y Paton
Drugs of Today (Barcelona, Spain : 1998)|May 18, 2016
PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemiaD M Paton
Lancet (London, England)|November 14, 1987
Aerosolised pentamidineW D Paton
Pageof 477

Showing results (351-360 of 4,763) with videos related to

Sort By:
Pageof 477
Drugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's diseaseD M Paton
Neuron|April 8, 2006
Shining light on spike timing-dependent plasticityMartha Constantine-Paton
Psychopharmacology Bulletin|January 1, 1994
Effects of NMDA receptor antagonists on the developing brainM Constantine-Paton
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1984
Classification of adenosine receptorsD M Paton
The Journal of Nursing Education|December 4, 2009
The professional practice knowledge of nurse preceptorsBrenda I Paton
Drugs of Today (Barcelona, Spain : 1998)|October 28, 2022
Somapacitan: a long-acting growth hormone derivative for treatment of growth hormone deficiencyDavid M Paton
International Journal of Clinical Pharmacology Research|January 1, 1986
Comparative bioavailability and half-lives of cloxacillin and flucloxacillinD M Paton
Postgraduate Medical Journal|January 24, 2013
Republished: perception of lung function, adherence to inhaled corticosteroids, and the role of peak expiratory flow feedback in paediatric asthmaJames Y Paton
Drugs of Today (Barcelona, Spain : 1998)|May 18, 2016
PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemiaD M Paton
Lancet (London, England)|November 14, 1987
Aerosolised pentamidineW D Paton
Pageof 477